For the quarter ended September 2025, Kenvue (KVUE Quick QuoteKVUE - Free Report) reported revenue of $3.76 billion, down 3.5% over the same period last year. EPS came in at $0.28, compared to $0.28 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $3.81 billion, representing a surprise of -1.31%. The company delivered an EPS surprise of +3.7%, with the consensus EPS estimate being $0.27.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Kenvue performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Sales- Self Care: $1.56 billion compared to the $1.59 billion average estimate based on two analysts. The reported number represents a change of -3.8% year over year.
• Net Sales- Essential Health: $1.16 billion compared to the $1.19 billion average estimate based on two analysts. The reported number represents a change of -3.3% year over year.
• Net Sales- Skin Health and Beauty: $1.04 billion versus $1.06 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change.

View all Key Company Metrics for Kenvue here>>>

Shares of Kenvue have returned -9.1% over the past month versus the Zacks S&P 500 composite's +2.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.